Copyright © 2008 Mauno Vanhala et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

1. M. L. X. Fu, “Do immune system changes have a role in hypertension?,” Journal of Hypertension, vol. 13, no. 11, pp. 1259–1265, 1995. View at Publisher · View at Google Scholar
2. Z. Pausova, B. Deslauriers, D. Gaudet, et al., “Role of tumor necrosis factor-$\alpha$ gene locus in obesity and obesity-associated hypertension in French Canadians,” Hypertension, vol. 36, no. 1, pp. 14–19, 2000.
3. J.-M. Fernandez-Real, M. Vayreda, C. Richart, et al., “Circulating interleukin 6 levels, blood pressure, and insulin sensitivity in apparently healthy men and women,” The Journal of Clinical Endocrinology & Metabolism, vol. 86, no. 3, pp. 1154–1159, 2001. View at Publisher · View at Google Scholar
4. H. D. Sesso, L. Wang, J. E. Buring, P. M. Ridker, and J. M. Gaziano, “Comparison of interleukin-6 and C-reactive protein for the risk of developing hypertension in women,” Hypertension, vol. 49, no. 2, pp. 304–310, 2007. View at Publisher · View at Google Scholar · View at PubMed
5. A. Syrenicz, B. Garanty-Bogacka, M. Syrenicz, A. Gebala, G. Dawid, and M. Walczak, “Relation of low-grade inflammation and endothelial activation to blood pressure in obese children and adolescents,” Neuroendocrinology Letters, vol. 27, no. 4, pp. 459–464, 2006.
6. L. Sun, Y. H. Gao, D. K. Tian, et al., “Inflammation of different tissues in spontaneously hypertensive rats,” Acta Physiologica Sinica, vol. 58, no. 4, pp. 318–323, 2006.
7. Y. Dörffel, C. Lätsch, B. Stuhlmüller, et al., “Preactivated peripheral blood monocytes in patients with essential hypertension,” Hypertension, vol. 34, no. 1, pp. 113–117, 1999.
8. V. M. Campese, Y. Shaohua, and H. Zhong, “Downregulation of neuronal nitric oxide synthase and and interleukin-1beta mediates angiotensin II-dependent stimulation of sympathetic nerve activity,” Hypertension, vol. 39, no. 2, part 2, pp. 519–524, 2002.
9. S. Ye, P. Mozayeni, M. Gamburd, H. Zhong, and V. M. Campese, “Interleukin-1$\beta$ and neurogenic control of blood pressure in normal rats and rats with chronic renal failure,” American Journal of Physiology, vol. 279, no. 6, pp. H2786–H2796, 2000.
10. M. Barbieri, L. Ferrucci, A. M. Corsi, et al., “Is chronic inflammation a determinant of blood pressure in the elderly?,” American Journal of Hypertension, vol. 16, no. 7, pp. 537–543, 2003. View at Publisher · View at Google Scholar
11. G. N. Dalekos, M. Elisaf, E. Bairaktari, O. Tsolas, and K. C. Siamopoulos, “Increased serum levels of interleukin-1$\beta$ in the systemic circulation of patients with essential hypertension: additional risk factor for atherogenesis in hypertensive patients?,” Journal of Laboratory and Clinical Medicine, vol. 129, no. 3, pp. 300–308, 1997.
12. N. Molnarfi, L. Gruaz, J.-M. Dayer, and D. Burger, “Opposite regulation of IL-1$\beta$ and secreted IL-1 receptor antagonist production by phosphatidylinositide-3 kinases in human monocytes activated by lipopolysaccharides or contact with T cells,” The Journal of Immunology, vol. 178, no. 1, pp. 446–454, 2007.
13. U. Salmenniemi, E. Ruotsalainen, J. Pihlajamäki, et al., “Multiple abnormalities in glucose and energy metabolism and coordinated changes in levels of adiponectin, cytokines, and adhesion molecules in subjects with metabolic syndrome,” Circulation, vol. 110, no. 25, pp. 3842–3848, 2004. View at Publisher · View at Google Scholar · View at PubMed
14. A. C. T. M. Peeters, M. G. Netea, M. C. H. Janssen, B. J. Kullberg, J. W. M. van der Meer, and T. Thien, “Pro-inflammatory cytokines in patients with essential hypertension,” European Journal of Clinical Investigation, vol. 31, no. 1, pp. 31–36, 2001. View at Publisher · View at Google Scholar
15. B. Vohnout, A. Di Castelnuovo, R. Trotta, et al., “Interleukin-1 gene cluster polymorphisms and risk of coronary artery disease,” Haematologica, vol. 88, no. 1, pp. 54–60, 2003.
16. H. Cha-Molstad, A. Agrawal, D. Zhang, D. Samols, and I. Kushner, “The Rel family member P50 mediates cytokine-induced C-reactive protein expression by a novel mechanism,” The Journal of Immunology, vol. 165, no. 8, pp. 4592–4597, 2000.
17. L. Niskanen, D. E. Laaksonen, K. Nyyssönen, et al., “Inflammation, abdominal obesity, and smoking as predictors of hypertension,” Hypertension, vol. 44, no. 6, pp. 859–865, 2004. View at Publisher · View at Google Scholar · View at PubMed
18. W. Vongpatanasin, G. D. Thomas, R. Schwartz, et al., “C-reactive protein causes downregulation of vascular angiotensin subtype 2 receptors and systolic hypertension in mice,” Circulation, vol. 115, no. 8, pp. 1020–1028, 2007. View at Publisher · View at Google Scholar · View at PubMed
19. S. J. Zieman, V. Melenovsky, and D. A. Kass, “Mechanisms, pathophysiology, and therapy of arterial stiffness,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 25, no. 5, pp. 932–943, 2005. View at Publisher · View at Google Scholar · View at PubMed
20. P. M. Ridker, J. E. Buring, J. Shih, M. Matias, and C. H. Hennekens, “Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women,” Circulation, vol. 98, no. 8, pp. 731–733, 1998.
21. W. Wang, E. T. Lee, R. R. Fabsitz, et al., “A longitudinal study of hypertension risk factors and their relation to cardiovascular disease: the strong heart study,” Hypertension, vol. 47, no. 3, pp. 403–409, 2006. View at Publisher · View at Google Scholar · View at PubMed
22. J. He, M. J. Klag, L. J. Appel, J. Charleston, and P. K. Whelton, “Seven-year incidence of hypertension in a cohort of middle-aged African Americans and whites,” Hypertension, vol. 31, no. 5, pp. 1130–1135, 1998.
23. G. Mancia, G. De Backer, A. Dominiczak, et al., “2007 Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC),” Journal of Hypertension, vol. 25, no. 6, pp. 1105–1187, 2007. View at Publisher · View at Google Scholar · View at PubMed
24. M. Ufnal, M. Dudek, T. Zera, and E. Szczepańska-Sadowska, “Centrally administered interleukin-1 beta sensitizes to the central pressor action of angiotensin II,” Brain Research, vol. 1100, no. 1, pp. 64–72, 2006. View at Publisher · View at Google Scholar · View at PubMed
25. C.-J. Zou, J.-D. Liu, and Y.-C. Zhou, “Roles of central interleukin-1 on stress-induced-hypertension and footshock-induced-analgesia in rats,” Neuroscience Letters, vol. 311, no. 1, pp. 41–44, 2001.
26. P. A. Sarafidis, A. I. Kanaki, and A. N. Lasaridis, “Statins and blood pressure: is there an effect or not?,” Journal of Clinical Hypertension, vol. 9, no. 6, pp. 460–467, 2007. View at Publisher · View at Google Scholar
27. J.-J. Li, Y.-S. Li, J.-M. Chu, et al., “Changes of plasma inflammatory markers after withdrawal of statin therapy in patients with hyperlipidemia,” Clinica Chimica Acta, vol. 366, no. 1-2, pp. 269–273, 2006. View at Publisher · View at Google Scholar · View at PubMed
28. M. A. Fisher, G. W. Taylor, B. J. Shelton, and S. Debanne, “Age and race/ethnicity-gender predictors of denying smoking, United States,” Journal of Health Care for the Poor and Underserved, vol. 19, no. 1, pp. 75–89, 2008. View at Publisher · View at Google Scholar · View at PubMed